StreetInsider.com News Articles

Haoxi Health closes $4M direct offering via Univest Securities

Mon, 13 Jul 2026 17:00:14 -0400

Haoxi Health Technology Ltd (NASDAQ: HAO), a Beijing-based online marketing services provider focused on China's healthcare sector, has closed a $4 million registered direct offering, with Univest Securities, LLC acting as sole placement agent, according to a press release.

Under the terms of the securities purchase agreement, the company sold 10,000,000 Class A ordinary shares, or pre-funded warrants in lieu thereof, at an offering price of $0.40 per share. The exercise price for the pre-funded warrants is $0.33 per share, with the purchase price equal to the share offering price less that exercise price amount.

The offering was made pursuant to a

Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

Mon, 13 Jul 2026 17:00:00 -0400

New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients.

Under the terms of the securities purchase agreement, the Company has agreed to sell to certain investors an aggregate of approximately $4 million

Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

Mon, 13 Jul 2026 17:00:00 -0400

Under the terms of the securities purchase agreement, the Company has agreed to sell to certain investors an aggregate of approximately $4 million

Form 6-K Haoxi Health Technology For: Jul 13

Mon, 13 Jul 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260713/26762633.html

Form 6-K Haoxi Health Technology For: Jul 13

Mon, 13 Jul 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260713/26762633.html

Form 424B5 Haoxi Health Technology

Mon, 13 Jul 2026 10:30:00 -0400

si-local-file:///var/storage/secattach/20260713/26761107.html

Form 424B5 Haoxi Health Technology

Mon, 13 Jul 2026 10:30:00 -0400

si-local-file:///var/storage/secattach/20260713/26761107.html

Haoxi Health plans $4M registered direct offering at $0.40 a share

Fri, 10 Jul 2026 13:15:10 -0400

Haoxi Health Technology Ltd (NASDAQ: HAO) has entered into a definitive agreement with certain investors for a registered direct offering of 10,000,000 Class A Ordinary Shares at $0.40 per share, or pre-funded warrants in lieu thereof, according to a press release from the Beijing-based company.

The aggregate gross proceeds from the offering are expected to be approximately $4 million. The shares carry a par value of $0.32 per share. Pre-funded warrants are priced at the same level as the shares, less an exercise price of $0.33 per share.

The transaction is expected to close on or about July 13, 2026, subject to

Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering

Fri, 10 Jul 2026 13:15:00 -0400

BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10,000,000 of the Company’s Class A Ordinary Shares, par value $0.32 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.40 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.33 per share.

The

Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering

Fri, 10 Jul 2026 13:15:00 -0400

The

Form 6-K Haoxi Health Technology For: Jul 06

Mon, 06 Jul 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260706/26735698.html

Form 6-K Haoxi Health Technology For: Jul 06

Mon, 06 Jul 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260706/26735698.html

Form 6-K Haoxi Health Technology For: Jun 24

Wed, 24 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260624/26685692.html

Form 6-K Haoxi Health Technology For: Jun 24

Wed, 24 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260624/26685692.html

Form 6-K Haoxi Health Technology For: Jun 04

Thu, 04 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605888.html

Form 6-K Haoxi Health Technology For: Jun 04

Thu, 04 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605888.html

Form 6-K Haoxi Health Technology For: May 21

Thu, 21 May 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260521/26536058.html

Form 6-K Haoxi Health Technology For: May 21

Thu, 21 May 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260521/26536058.html

Form 4 Haoxi Health Technology For: May 19 Filed by: Fan Zhen

Wed, 20 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260520/26528556.html

Form 4 Haoxi Health Technology For: May 19 Filed by: Fan Zhen

Wed, 20 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260520/26528556.html

Form 6-K Haoxi Health Technology For: May 19

Tue, 19 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260519/26521325.html

Form 6-K Haoxi Health Technology For: May 19

Tue, 19 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260519/26521325.html

Haoxi Health Technology announces 1-for-128 reverse stock split

Tue, 19 May 2026 08:30:14 -0400

Haoxi Health Technology Limited (NASDAQ: HAO) announced it will implement a 1-for-128 reverse stock split of its outstanding Class A and Class B ordinary shares, effective May 21, 2026.

The reverse split will reduce the number of outstanding Class A ordinary shares from 235,504,007 to approximately 1,839,876, and Class B ordinary shares from 690,800 to approximately 5,397. The par value of both share classes will increase from $0.0025 to $0.32 per share.

Following the split, Class A ordinary shares will continue trading on Nasdaq under the symbol "HAO" with a new CUSIP number G4290F126. The company expects shares to trade at approximately

Haoxi Health Technology announces 1-for-128 reverse stock split

Tue, 19 May 2026 08:30:14 -0400

Haoxi Health Technology Limited (NASDAQ: HAO) announced it will implement a 1-for-128 reverse stock split of its outstanding Class A and Class B ordinary shares, effective May 21, 2026.

Following the split, Class A ordinary shares will continue trading on Nasdaq under the symbol "HAO" with a new CUSIP number G4290F126. The company expects shares to trade at approximately

Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split

Tue, 19 May 2026 08:30:00 -0400

BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the “Class A Ordinary Shares”) and Class B ordinary shares, par value $0.0025 per share (the “Class B Ordinary Shares”), at a ratio of 1-for-128.

Our Class A Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market (“Nasdaq”) on May 21, 2026. Following the reverse share